Compiles 195 contributions from the June 1996 meeting. Part I (clinical aspects and pathology) discusses the role of neuroprotection and neurorescue in ischemia, stroke, and neuronal injury, as well as neurochemical mechanisms, mood disorders, and the significance of cerebrospinal fluid examinations
Compiles 195 contributions from the June 1996 meeting. Part I (clinical aspects and pathology) discusses the role of neuroprotection and neurorescue in ischemia, stroke, and neuronal injury, as well as neurochemical mechanisms, mood disorders, and the significance of cerebrospinal fluid examinationsHinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
History. Clinical Aspects and Pathology: New Aspects of Alzheimer's and Other Neurodegenerative Diseases. Antidepressant and Anxiolytic Mechanisms of Serotonergic Autoreceptor Agonists. Antagonists and Reuptake Inhibitors. Mild Hypothermia in the Management of Stroke and Other Ischemic Brain Trauma; Basic Mechanisms and Clinical Experience, Neurochemistry and Neuroimmunology of EAE; Implications for Therapy of MS. Neuroprotection in Model Studies for Dementia and Ischemia. Pathogenic Mechanisms in Mood Disorders. Atypical Antipsychotics: The Neurochemical Relevance of Test Models. Cellular Functions: Neurotrophic Molecules in Development and Regeneration. Steroids and Nervous System. Molecular Mechanisms of Microglial Activation. Metabolic Trafficking in the Brain. The Functional Role of Chromogranins and Related Peptides. Role of Melatonin in the Brain and Eye. Transporters for Essential Nutrients in Brain Cells. Molecules/Methods: Neurotransmitter Transporters. Structures of Neuronal Proteins in Rationalized Drug Design. Progress in Cholinergic Neurotransmission. Cell Adhesion in Neural Plasticity Induced by Experience. Expression and Metabolism of Glycoconjugates. CNS Taurine-A New Outlook. 23 Additional Chapters. Index.
History. Clinical Aspects and Pathology: New Aspects of Alzheimer's and Other Neurodegenerative Diseases. Antidepressant and Anxiolytic Mechanisms of Serotonergic Autoreceptor Agonists. Antagonists and Reuptake Inhibitors. Mild Hypothermia in the Management of Stroke and Other Ischemic Brain Trauma; Basic Mechanisms and Clinical Experience, Neurochemistry and Neuroimmunology of EAE; Implications for Therapy of MS. Neuroprotection in Model Studies for Dementia and Ischemia. Pathogenic Mechanisms in Mood Disorders. Atypical Antipsychotics: The Neurochemical Relevance of Test Models. Cellular Functions: Neurotrophic Molecules in Development and Regeneration. Steroids and Nervous System. Molecular Mechanisms of Microglial Activation. Metabolic Trafficking in the Brain. The Functional Role of Chromogranins and Related Peptides. Role of Melatonin in the Brain and Eye. Transporters for Essential Nutrients in Brain Cells. Molecules/Methods: Neurotransmitter Transporters. Structures of Neuronal Proteins in Rationalized Drug Design. Progress in Cholinergic Neurotransmission. Cell Adhesion in Neural Plasticity Induced by Experience. Expression and Metabolism of Glycoconjugates. CNS Taurine-A New Outlook. 23 Additional Chapters. Index.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
